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INTRODUCTION
Melanoma	 with	 oral	 location	 is	 a	 common	
malignant	neoplasm	in	dogs,	affecting	mostly	older	
animals	(Bostock,	1979;	Gilard	et al.,	2014;	Nishiya	
et al.,	 2016;	 Ogilvie	 and	Moore,	 1988;	 Ramos	 et 
al.,	 2000;	 Thomas	 and	 Fox,	 1998).	 Canine	 oral	
melanoma	 represents	 between	 14.4	 and	 45.5%	
of	 oral	 tumors	 (Nishiya	 et al.,	 2016;	 Todoroff	
and	Brodey,	 1979).	 	 The	 breeds	most	 commonly	
affected	 are:	 Poodle,	 Dachshund,	 terriers	 and	
Golden	 Retriever,	 Chow	 Chow,	 Boxer,	 Rottweiler	
(Gilard	et al.,	2014;	Modiano	et al.,	1999;	Ogilvie	
and	Moore,	1988).	
Canine	 melanomas	 are	 classified	 into	 two	
types:	melanotic	and	amelanotic,	based	on	terms	
of	 clinical	 behavior,	 cells’	 multiplication	 and	
connexin	 expression	 (Teixeira	 et al.,	 2014).	 The	
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Abstract
Treatment	 of	 oral	melanomas	 utilizes	 the	 surgical	 excision-resection	 (Culp	 et al.,	 2013)	 and/or	 radiation	
therapy	(Proulx	et al.,	2003),	chemotherapy	with	carboplatin	(Brockley	et al.,	2013),	immunotherapy	(Ottnod	et 
al.,	2013).	Treatment	based	on	surgical	excision	is	usually	palliative	(Freeman	et al.,	2003).	In	the	literature	even	
though	there	are	data	concerning	the	prognosis	of	oral	melanomas	in	dogs	after	surgery,	are	missing	data	after	
laser	excision.	Taking	into	account	these	findings	we	wished	to	present	our	experience	regarding	three	cases	of	
oral	melanoma	recurrence	and	immediate	and	long	term	laser	surgery	results.
The	 casuistry	 consisted	 of	 three	 dogs	 with	 recurrent	 oral	 malignant	 melanomas,	 subjected	 to	 surgical	
reintervention.	The	initial	diagnosis	was	melanotic	melanoma	in	stage	I	or	II.	The	animals	were	brought	back	at	
different	time	intervals	from	originally	excision	with	electric	scalpel.	Before	reintervention,	dogs	were	subjected	
to	 clinical,	 paraclinical	 exam	and	biopsy.	Excision	of	 the	 tumor	mass	was	made	with	an	optical	 fiber	hawing	a	
diameter	of	400µm,	at	a	power	of	10W	and	a	wavelength	of	940	nm	with	a	diode	laser.	At	1,	2,	3,	6	and	12	months	
after	 laser	 reintervention	 the	 dogs	were	 reexamined.	 Average	 time	 in	which	 appeared	 canine	 oral	melanoma	
relapse	was	58.6	days.	After	reexamination	all	cases	where	reinstatement	in	stage	I.	Operators	times	were	held	
in	conditions	of	comfort	with	wide	access,	minimum	bleeding,	and	effective	hemostasis.	After	surgery	at	24	hours	
on	the	intervention	place	a	slight	local	redness,	without	swelling	and	bleeding	was	observed.	Palpation	revealed	
initially	 also	 a	 slight	 local	 sensitivity	which	 completely	 disappeared	 in	 48	 hours.	 There	were	 no	 grasping	 and	
chewing	disturbances.	Macroscopic	healing	occurred	in	7-9	days.	At	last	recheck	performed	at	12	months	there	
were	no	evidences	of	tumor	recurrence	or	metastasis.	Diode	laser	excision	of	oral	malignant	melanoma	in	dogs	can	
be	an	alternative	palliative	procedure	to	invasive	surgical	resection	procedures.	The	average	of	free	recurrence	and	
metastasis	time	after	laser	surgery	has	exceeded	360	days	in	these	three	cases.
Keywords: canine oral melanoma, diode laser
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amelanotic	variant	 is	very	aggressive	(Teixeira	et 
al.,	2014).
Treatment	 of	 oral	 melanomas	 utilizes	 the	
surgical	 excision-resection	 (Bradley	 et al.,	 1984;	
Culp	et al.,	2013;	Felizzola	et al.,	2002;	Kosovsky	
et al.,	1991;	Wallace	et al.,	1992)	and/or	radiation	
therapy	(	Proulx	et al.,	2003;	Freeman	et al.,	2003),	
chemotherapy	 with	 carboplatin	 (Brockley	 et al.,	
2013;	 Freeman	 et al.,	 2003),	 immunotherapy	 -	
vaccines	with	dendritic	cells	(Grosenbaugh	et al.,	
2011;	Ottnod	et al.,	2013).
The	indicated	treatment	is	based	on	extensive	
surgical	 resection	 -	 hemi	 mandibulectomy	 or	
maxillectomy	 (Bradley	 et al.,	 1984;	 Felizzola	 et 
al.,	 2002;	 Kosovsky	 et al.,	 1991;	 Wallace	 et al.,	
1992).	 Treatment	 based	 on	 surgical	 excision	 is	
usually	 palliative	 (Culp	 et al.,	 2013;	 Freeman	 et 
al.,	 2003)	 with	 few	 studies	 reporting	 a	 curative	
action,	canine	oral	melanoma	having	a	high	rate	of	
relapse	 -	 3-28%	 (Culp	et al.,	 2013;	Esplin,	 2008;	
Tuohy	et al.,	2014)	and	development	of	metastasis.	
The	rate	of	metastasis	of	oral	melanoma	in	dogs	is	
between	14	and	92%	(Nishiya	et al.,	2016;	Ramos	
et al.,	2000;	Williams	and	Packer,	2003),	with	an	
average	 of	 about	 80%	 (Thomas	 and	 Fox,	 1998).	
The	median	 survival	 time	post-surgery	 (classical	
surgery)	 in	dogs	with	oral	melanoma	 is	147-241	
days	(Brockley	et al.,	2013;	Culp	et al.,	2013).
In	 the	 literature	 even	 though	 there	 are	 data	
concerning	 the	 prognosis	 of	 oral	 melanomas	 in	
dogs	 after	 surgery	 (Bostok-1979;	 Esplin,	 2008;	
Hahn	et al.,	1994;	Harvey	et al.,	1981;	MacEwen	et 
al.,	1986;	Smedley	et al.	2011;	Tuohy	et al.,	2014),	
data	 on	 the	 prognosis	 after	 laser	 excision	 are	
missing.
In	this	case	report	are	presented	data	recorded	
by	 laser	 excision	 of	 oral	malignant	melanoma	 in	
dogs.
MATERIALS AND METHODS
The	 casuistry	 included	 in	 this	 study	 -	 table	
1,	 consisted	 of	 three	 dogs	 with	 recurrent	 oral	
malignant	 melanomas,	 subjected	 to	 surgical	
reintervention	 by	 laser	 excision	 of	 the	 tumor	
masses.
The	 initial	 diagnosis	 was	 established	 by	
clinical,	 radiographic	 and	 histological	 exam,	 in	
all	 three	 cases	 being	 melanotic	 melanoma	 in	
stage	 I	 or	 II,	 according	 to	 TNM	 classification	
(tumor,	 lymph	 node,	 metastasis)	 of	 the	 World	
Health	 Organization	 for	 oropharyngeal	 tumors	
(Bergman	2007;	Freeman	et al.,	2013),	T	-	tumor	
cm	in	diameter,	a-b	-	mitotic	 index	no/field	1-2	-	
location	 (1-	 rostral	mandible/caudal	maxilla;	 2	 -	
another),	N	-	lymph	nodes	involvement,	M	-	distant	
metastases).	The	animals	were	presented	again	in	
the	 Surgery	 Clinic	 of	 FMV	Timisoara	 at	 different	
time	 intervals	 (table	 1)	 from	 classical	 surgical	
intervention	 performed	 originally	 (excision	with	
electric	scalpel).	
The	 time	 interval	 without	 relapse	 was	
calculated	 between	 the	 time	 of	 the	 first	 surgery	
and	time	of	 the	owner	presentation	to	signal	 the	
relapse	 observed	 macroscopically.	 Decision	 for	
surgical	 reintervention	 was	 taken	 after	 owners’	
refusal	 to	 accept	 an	 invasive	 surgical	 procedure	
(mandibulectomy	or	maxillectomy).	
Before	 surgical	 reintervention,	 the	 dogs	
were	 subjected	 to	 clinical	 and	 paraclinical	 exam	
(complete	 physical	 examination,	 thorough	 oral	
IGNA et al
Tab.1. Casuistry	of	relapsed	canine	malignant	melanoma 
No Breed Ageyears
Weight
kgs Sex The initial diagnosis
Time interval after 
which the relapse 
has occured
days
1 Poodle 12 9 M Palatal melanoma with rostral location 
stage I		-	T
1
a2, N
0
, M0 36
2 Rottweiler 9 36 M Gingival right jaw melanoma with caudal location 
stage II		-	T
2
a1, N
0
, M0 95
3
German 
Shepherd
12 32 F
Gingival maxilla melanoma with 
rostral location 
stage II		-	T
2
a1, N
0
, M0 45
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examination,	palpation	of	peripheral	lymph	nodes,	
chest	 radiography,	 complete	 blood	 count	 and	
blood	biochemical	analysis).	Clinical	examination	
revealed	 no	 respiratory	 changes	 and	 no	
changes	 in	volume	of	 regional	 lymph	nodes.	The	
paraclinical	exam	and	imaging	investigations	were	
unremarkable.	From	biopsy	samples	taken	before	
surgery,	 fresh	 cytological	 specimens	 were	 made	
by	tissue	samples	mark	on	glass	microscope	slides	
and	were	stained	with	Diff-Quick,	confirming	the	
relapse.
The	protocol	for	general	anaesthesia	included	
premedication	 with	 diazepam	 (0.4	 mg/kg	 b.w.,	
i.v.)	and	ketamine	(5	mg/kg	b.w.,	i.v.),	followed	by	
induction	with	propofol	(3	mg/kg	b.w.,	i.v.).	After	
endotracheal	intubation,	general	anaesthesia	was	
maintained	 with	 izoflurane	 vaporized	 in	 oxygen	
using	 intermittent	 positive	 pressure	 ventilation.	
Postoperative	 analgesia	 was	 provided	 with	
one	 dose	 of	 butorphanol	 (0.4	 mg/kg	 b.w.,	 s.c.)	
administered	within	15	minutes	before	recovery.	
Ampicillin	 (20	mg/kg	b.w,	 i.v.)	was	administered	
at	induction	and	at	the	end	of	surgery,	which	lasted	
two	hours.	
The	dogs	were	placed	in	recumbency	(dorsal	
or	 sterno-abdominal)	with	 the	neck	 in	extension	
and	mouth	held	open	with	a	speculum.
Excision	of	the	tumor	mass	was	made	with	an	
optical	fiber	having	a	diameter	of	400µm,	at	a	power	
of	10W	and	a	wavelength	of	940	nm	with	a	diode	
laser	(Dornier	Medilas	D	LiteBeam	+	Germany),	in	
contact,	working	mode	continuous	wave	-	figure	1.	
The	device	is	equipped	with	Lightguide	Protection	
System,	 thereby	 preventing	 the	 overheat	 of	
local	 tissue	and	damage	of	 the	optical	 fiber.	Oral	
mucosa	and	 submucosal	 incision	was	performed	
in	 presumed	 healthy	 tissue	 at	 a	 distance	 of	 1-2	
cm	from	the	 tumor	mass.	After	excision,	 the	oral	
Fig. 3.	Initial preoperative appearance Fig. 4.	Appearance	of	the	relapse
Fig. 1.	Diode	laser	excision Fig. 2.	Oral	mucosa	apposed	in	a	simple	interrupted	
sutures
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mucosa	was	sutured	in	simple	interrupted	sutures	
using	PDS	II	(2	metric)	-	figure	2.
Postoperatively,	 in	 the	 first	 10	 days,	 the	
animals	were	clinically	examined	daily	observing:	
local	pain	on	palpation,	local	swelling,	presence	of	
hemorrhage,	 the	appearance	of	operative	wound	
and	speed	of	healing.
At	 1,	 2,	 3,	 6	 and	 12	 months	 after	 laser	
reintervention,	the	dogs	were	clinically	examined	
(complete	 physical	 examination,	 thorough	 oral	
examination,	 palpation	 of	 peripheral	 lymph	
nodes)	 and	 imagistically	 (thoracic	 -	 abdominal	
radiographs	for	evidence	of	metastasis).
RESULTS AND DISCUSSION
For	 the	 three	 cases	 included	 in	 this	 study	
(table	 1)	 mean	 age	 was	 11	 years	 (range,	 9-12	
years)	 with	 an	 average	 body	 weight	 of	 25.6	 kg	
(range,	9-36	kg).
Average	time	in	which	canine	oral	melanoma	
has	 relapsed	was	 58.6	 days	 (range,	 36-95	 days),	
ascertaining	 the	halving	of	 it,	when	compared	 to	
data	 from	 the	 literature	 (Freeman	 et al.,	 2013)	
which	mentions	a	median	time	without	recurrence	
of	139	days.
Compared	 to	 the	 initial	 stadialization	 (table	
1),	 one	 case	 of	 malignant	 oral	 melanoma	 stage	
I	 (T
1
a2,	 N
0
,	 M
0
)	 and	 two	 cases	 of	 stage	 II	 (T
2
a1,	N
0
,	 M
0
),	 clinical	 and	 radiographic	 examinations	
made	before	surgical	 reintervention,	allowed	 the	
reinstatement	of	 these	 three	cases	 in	 stage	 I	 (T
1
,	N
0
,	M
0
)	but	without	determining	the	mitotic	index	
-	fig.	3	and	4.	There	are	studies	(Ramos	et al.,	2000)	
showing	that	there	were	no	statistically	significant	
differences	 regarding	 tumor	 location,	 mitotic	
index,	relapse-free	interval	and	survival	range.
During	laser	reintervention	the	surgigcal	steps	
were	 conducted	 in	 conditions	 of	 comfort	 with	
wide	 access,	 minimum	 intraoperative	 bleeding,	
effective	hemostasis	-	fig.	5	and	6,	confirming	the	
advantages	of	using	diode-laser	in	oral	surgery	in	
dogs	(De	Lorenzi	et al.,	2015).
After	 laser	 reintervention	 at	 24	 hours,	 in	
all	 three	 dogs	 on	 the	 intervention	 site	 a	 slight	
local	 redness	 was	 observed,	 without	 swelling	
nor	 bleeding.	 Palpation	 of	 the	 intervention	 site	
also	 revealed	 initially	 (24	 hours)	 a	 slight	 local	
sensitivity	 which	 completely	 disappeared	 in	 48	
hours,	all	dogs	resuming	to	normal	eating	behavior.	
There	were	no	grasping	and	chewing	disturbances.	
Macroscopic	operative	wound	healing	occurred	in	
7-9	days,	allowing	removal	of	suture	materials-	fig	
7.
At	 recheck,	 performed	 at	 1,	 2,	 3,	 6	 and	
respectively	 12	 months	 from	 the	 laser	 re-
intervention,	 there	were	no	evidences	of	 tumour	
recurrence	 nor	 metastasis.	 Comparison	 of	 the	
obtained	data	with	those	reported	in	other	studies	
(Bergman,	2007;	Freeman	et al.,	2013;	Nishiya	et 
al.,	2016)	require	as	a	future	need	the	Smedley	et 
al.,	2011	opinion	to	guide	the	research	for	“more 
rigorous prospective studies, especially to evaluate 
specific treatment protocols, that would enable a 
more targeted therapy”.
IGNA et al
Fig. 5.	Intraoperative appearance - 
laser surgery 
Fig. 6.	Intraoperative 
appearance of intervention 
place
Fig. 7.	At	seven	days
269
Bulletin UASVM Veterinary Medicine 73 (2) / 2016
CONCLUSION
Diode	 laser	 excision	 of	 oral	 malignant	
melanoma	in	dogs	can	be	an	alternative	palliative	
procedure	 to	 invasive	 surgical	 resection	
procedures.
The	average	of	free	recurrence	and	metastasis	
time	after	laser	surgery	has	exceeded	360	days	in	
those	three	cases.
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